In summary, HsTx2 treatment significantly protects against the progression of epilepsy through a mechanism that mainly depends on anti-inflammatory activity by regulating the circ_0001293/miR-8114/TGF-β2 axis. This evidence concerns the gene TGFB2 and epilepsy.